Annual Cash & Cash Equivalents
$3.29 M
-$1.83 M-35.69%
December 1, 2023
Summary
- As of March 10, 2025, LIPO annual cash & cash equivalents is $3.29 million, with the most recent change of -$1.83 million (-35.69%) on December 1, 2023.
- During the last 3 years, LIPO annual cash & cash equivalents has risen by +$2.69 million (+442.89%).
- LIPO annual cash & cash equivalents is now -35.69% below its all-time high of $5.12 million, reached on December 31, 2022.
Performance
LIPO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.35 M
+$167.20 K+14.09%
September 1, 2024
Summary
- As of March 10, 2025, LIPO quarterly cash and cash equivalents is $1.35 million, with the most recent change of +$167.20 thousand (+14.09%) on September 1, 2024.
- Over the past year, LIPO quarterly cash and cash equivalents has stayed the same.
- LIPO quarterly cash and cash equivalents is now -73.57% below its all-time high of $5.12 million, reached on December 31, 2022.
Performance
LIPO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LIPO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.7% | 0.0% |
| 3 y3 years | +442.9% | 0.0% |
| 5 y5 years | +442.9% | 0.0% |
LIPO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.7% | +133.0% | -73.6% | +1079.2% |
| 5 y | 5-year | -35.7% | +442.9% | -73.6% | +1079.2% |
| alltime | all time | -35.7% | +442.9% | -73.6% | +1079.2% |
Lipella Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.35 M(+14.1%) |
| Jun 2024 | - | $1.19 M(-43.6%) |
| Mar 2024 | - | $2.11 M(-36.1%) |
| Dec 2023 | $3.29 M(-35.7%) | $3.29 M(+36.7%) |
| Sep 2023 | - | $2.41 M(-22.6%) |
| Jun 2023 | - | $3.11 M(-22.5%) |
| Mar 2023 | - | $4.02 M(-21.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $5.12 M(+262.3%) | $5.12 M(+4361.4%) |
| Sep 2022 | - | $114.80 K(-73.6%) |
| Jun 2022 | - | $435.00 K(+5.0%) |
| Mar 2022 | - | $414.40 K(-70.7%) |
| Dec 2021 | $1.41 M(+133.0%) | - |
| Dec 2021 | - | $1.41 M |
| Dec 2020 | $606.70 K | - |
FAQ
- What is Lipella Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Lipella Pharmaceuticals?
- What is Lipella Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Lipella Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Lipella Pharmaceuticals?
- What is Lipella Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Lipella Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of LIPO is $3.29 M
What is the all time high annual cash & cash equivalents for Lipella Pharmaceuticals?
Lipella Pharmaceuticals all-time high annual cash & cash equivalents is $5.12 M
What is Lipella Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, LIPO annual cash & cash equivalents has changed by -$1.83 M (-35.69%)
What is Lipella Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LIPO is $1.35 M
What is the all time high quarterly cash and cash equivalents for Lipella Pharmaceuticals?
Lipella Pharmaceuticals all-time high quarterly cash and cash equivalents is $5.12 M
What is Lipella Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, LIPO quarterly cash and cash equivalents has changed by $0.00 (0.00%)